Evaluating the financial burdens of stem cell therapy is crucial for patients and policymakers alike. One significant factor influencing these costs is the Consumer Price Index (CPI). As healthcare expenses continue to rise, tracked by the CPI, stem cell treatments are becoming more expensive. Understanding this relationship allows for in-depth ana

Publisher’s Observe: MDPI stays neutral regarding jurisdictional claims in published maps and institutional affiliations. The FDA also details out other safety considerations, like injection site reactions, the ability of stem cells injected into just one Element of the body to migrate to a different element, failure of cells to work as anticipa